Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-17

Clinical Trial Update: The Safety of Dapoxetine/Tadalafil Combination Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the safety of a dapoxetine/tadalafil combination therapy for premature ejaculation and erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • dapoxetine/tadalafil combination therapy (dapoxetine plus tadalafil)

Snippet

Sponsor: Neutec Ar-Ge San ve Tic A.Ş | Conditions: Premature Ejaculation, Erectile Dysfunction | Phase 4 | Status: UNKNOWN